Comparison of Blended Care Outpatient Neurorehabilitation With Traditional Outpatient Neurorehabilitation

NCT07458308 | Enrolling By Invitation DMC

• 1 other identifier: Comparison of blended care
• Study Type: interventional
• Target: 30
• Locations: 1 country
• Sites: 1

Brief Summary

What is this study about? Outpatient neurorehabilitation (therapy after leaving the hospital) is an important follow-up treatment for people who have had a stroke, brain bleeding, or serious head injury. It helps improve problems with movement, speech, memory, or daily activities. At the same time, there are not enough healthcare professionals, and healthcare costs are rising. Because of this, we need new and more efficient ways to provide therapy. One possible solution is telerehabilitation. This means patients do part of their therapy at home using video calls and apps. Early studies show that this can work well. However, in Switzerland it is still rarely used. One reason is that digital therapies are often not paid for, and there is still limited scientific proof of how effective they are. In this study, the investigators want to find out how well a combination of traditional in-person therapy and digital therapy at home works. The goal is to make treatment more modern, effective, and affordable - benefiting patients, therapists, and the healthcare system. How is the study organized? Participants in the study are randomly divided into two groups. Group 1: First, participants have three weeks of combined therapy:

1. 1.therapy day per week at the hospital.
2. 2.therapy days per week at home via Microsoft Teams video calls. On home days, participants also complete exercises using apps provided by their therapists.

Conditions

Stroke; Intracerebral Haemorrhage; Brain Trauma

Keywords

outpatient neurorehabilitation; Blended care/Telerehabilitation; Outcome

Outcome Measures

Primary Outcomes (1)

• The change in total sum score between start and end of the 2 phases of the cross over periods on the Lucerne International Classification of Functioning, Disability and Health(ICF) -based Multidisciplinary Observation Scale (LIMOS)

  Minimum Value: 45 Maximum Value: 225 Higher Scores mean better outcome

  From start to end of the first crossover phase (Start of study - 3 weeks) and start to end of the second crossover phase (3 weeks - 6 weeks), follow-up at 3 months after end of the whole intervention phase

Study Arms (2)

Start with traditional outpatient neurorehabilitation, cross over to blended care after 3 weeks

ACTIVE COMPARATOR

traditional outpatient neurorehabilitation consists of a mean of 3 days of interdisciplinary therapies per week on site, blended care consists of 2 days of therapies in home setting and 1 day of therapies on site

Other: Blended care outpatient neurorehabilitation

Start with blended care, cross over to traditional outpatient neurorehabilitation after 3 weeks

EXPERIMENTAL

Other: Blended care outpatient neurorehabilitation

Interventions

Blended care outpatient neurorehabilitation OTHER

Combination of telerehabilitation in the patients' home setting and outpatient neurorehabilitation on site

Start with blended care, cross over to traditional outpatient neurorehabilitation after 3 weeks; Start with traditional outpatient neurorehabilitation, cross over to blended care after 3 weeks

Eligibility Criteria

• Age: 18 Years - 80 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Diagnosis of ischemic or haemorragic stroke or brain trauma.
• People for whom at least 6 weeks of outpatient rehabilitation is foreseen to be indicated.
• Ability for safe independent mobilisation (screening with MiniBesTest, Chedoke)
• Access to and ability to operate MS Teams and Apps on computer and other digital devices (Smartphone, Tablet) (Screening with AST, LAST and NHPT)
• Able to provide informed consent in German.
• Age: 18 - 80 years

You may not qualify if:

• Severe cardiopulmonary disease
• Inability to provide informed consent

Sponsors & Collaborators

• Luzerner Kantonsspital: lead

Study Sites (1)

Luzerner Kantonsspital

Lucerne, Switzerland

Location

MeSH Terms

Conditions

Stroke; Cerebral Hemorrhage; Brain Injuries, Traumatic

Condition Hierarchy (Ancestors)

Cerebrovascular Disorders; Brain Diseases; Central Nervous System Diseases; Nervous System Diseases; Vascular Diseases; Cardiovascular Diseases; Intracranial Hemorrhages; Hemorrhage; Pathologic Processes; Pathological Conditions, Signs and Symptoms; Brain Injuries; Craniocerebral Trauma; Trauma, Nervous System; Wounds and Injuries

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Purpose: TREATMENT
• Intervention Model: CROSSOVER
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: MD, PhD

Study Record Dates

• First Submitted: March 3, 2026
• First Posted: March 9, 2026
• Study Start: April 7, 2026
• Primary Completion (Estimated): March 1, 2029
• Study Completion (Estimated): June 1, 2029
• Last Updated: April 13, 2026

Record last verified: 2026-04

Locations

CH (1)